| Year |
Citation |
Score |
| 2022 |
Khatri K, Richardson CM, Glesner J, Kapingidza AB, Mueller GA, Zhang J, Dolamore C, Vailes LD, Wünschmann S, Peebles RS, Chapman MD, Smith SA, Chruszcz M, Pomés A. Human IgE monoclonal antibody recognition of mite allergen Der p 2 defines structural basis of an epitope for IgE cross-linking and anaphylaxis . Pnas Nexus. 1: pgac054. PMID 35799831 DOI: 10.1093/pnasnexus/pgac054 |
0.303 |
|
| 2021 |
Joosse BA, Jackson JH, Cisneros A, Santhin AB, Smith SA, Moore DJ, Crofford LJ, Wilfong EM, Bonami RH. High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors. Frontiers in Immunology. 12: 685718. PMID 34234784 DOI: 10.3389/fimmu.2021.685718 |
0.681 |
|
| 2021 |
Young-Glazer J, Cisneros A, Wilfong EM, Smith SA, Crofford LJ, Bonami RH. Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients. Arthritis Research & Therapy. 23: 33. PMID 33468230 DOI: 10.1186/s13075-020-02412-8 |
0.675 |
|
| 2020 |
Ferastraoaru D, Rosenstreich D, Smith S. IgE deficient patients have no IgE-encoding B cells in the periphery – a pilot study The Journal of Allergy and Clinical Immunology. 145. DOI: 10.1016/J.Jaci.2019.12.417 |
0.391 |
|
| 2020 |
Richardson C, Glesner J, Kapingidza A, Bracaglia J, Chapman M, Chruszcz M, Smith S, Pomes A. Recombinant expression of human IgE antibody constructs for analysis of antigenic determinants on dust mite allergens The Journal of Allergy and Clinical Immunology. 145. DOI: 10.1016/J.Jaci.2019.12.328 |
0.358 |
|
| 2019 |
Newman JH, Shaver A, Sheehan JH, Mallal S, Stone JH, Pillai S, Bastarache L, Riebau D, Allard-Chamard H, Stone WM, Perugino C, Pilkinton M, Smith SA, McDonnell WJ, Capra JA, et al. IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells. Molecular Genetics & Genomic Medicine. e686. PMID 30993913 DOI: 10.1002/Mgg3.686 |
0.436 |
|
| 2018 |
Smith SA, Burton SL, Kilembe W, Lakhi S, Karita E, Price M, Allen S, Derdeyn CA. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120. Frontiers in Immunology. 9: 3163. PMID 30697215 DOI: 10.3389/Fimmu.2018.03163 |
0.316 |
|
| 2016 |
Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS. Functional transplant of a DENV3-specific human monoclonal antibody epitope into DENV1. Journal of Virology. PMID 26962223 DOI: 10.1128/Jvi.00155-16 |
0.306 |
|
| 2015 |
Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE. Dengue virus prM-specific human monoclonal antibodies with virus replication enhancing properties recognize a single immunodominant antigenic site. Journal of Virology. PMID 26512092 DOI: 10.1128/Jvi.01805-15 |
0.685 |
|
| 2015 |
Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomadiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, et al. Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host & Microbe. 18: 86-95. PMID 26159721 DOI: 10.1016/J.Chom.2015.06.009 |
0.692 |
|
| 2015 |
Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nature Communications. 6: 6341. PMID 25698059 DOI: 10.1038/ncomms7341 |
0.307 |
|
| 2014 |
de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, Crowe JE, Wang WK, Harris E, de Silva AM. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. Plos Pathogens. 10: e1004386. PMID 25275316 DOI: 10.1371/Journal.Ppat.1004386 |
0.314 |
|
| 2014 |
Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE. Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones. Journal of Virology. 88: 12233-41. PMID 25100837 DOI: 10.1128/JVI.00247-14 |
0.373 |
|
| 2013 |
Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. Mbio. 4: e00873-13. PMID 24255124 DOI: 10.1128/Mbio.00873-13 |
0.322 |
|
| 2012 |
Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, Crowe JE. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. Journal of Virology. 86: 2665-75. PMID 22171265 DOI: 10.1128/JVI.06335-11 |
0.349 |
|
| 2011 |
Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, Basler CF, Crowe JE. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. Journal of Immunology (Baltimore, Md. : 1950). 187: 3704-11. PMID 21880983 DOI: 10.4049/Jimmunol.1101823 |
0.685 |
|
| Show low-probability matches. |